Page 18 - கதிரியக்கவியல் சமூகம் ஆஃப் வடக்கு அமெரிக்கா News Today : Breaking News, Live Updates & Top Stories | Vimarsana

email article In recognition of the 50th anniversary of the National Cancer Act, retiring chief medical officer Richard Schilsky, MD, of the American Society of Clinical Oncology (ASCO), reviews progress and major advances in cancer that have occurred since 1971. A year after posting a negative trial in metastatic bladder cancer, AstraZeneca has voluntarily withdrawn the indication for durvalumab (Imfinzi) in the U.S. after consultation with the FDA. ( Endpoints News) ASCO and Cancer Care Ontario published updated guidance for treating metastatic non-small cell lung cancer (NSCLC) associated with targetable mutations. Sanofi and Regeneron announced FDA approval of cemiplimab (Libtayo) for first-line treatment of metastatic NSCLC with PD-L1 expression ≥50%.

United statesRichard schilskyCharles bankheadAmerican association for cancer researchLangone healthAmerican society of clinical oncologyNational cancerRadiological society of north americaAmerican roentgen ray societyNational cancer actAmerican societyClinical oncologyEndpoints newsCancer care ontarioLancet oncologyMedpage today